HK Stock Market Move | MEDBOT-B(02252) rose more than 5%. Siasun Robot & Automation has a wide market space. The company's total orders for core products last year exceeded one hundred units.

MEDBOT-B(02252) rose by more than 5%, rising by 5.59% to HK $24.55 with a trading volume of HK $401 million as of the time of publication. On the news front, in recent years, the global surgical Siasun Robot & Automation market has seen explosive growth. According to Frost & Sullivan's forecast, by 2030, the market size of China's surgical Siasun Robot & Automation will exceed 70 billion yuan, with an annual compound growth rate of over 30%. According to previous disclosures by Micro Siasun Robot & Automation, the company's comprehensive order volume for its flagship products in laparoscopy, orthopedics, and vascular intervention has exceeded 100 units. During this period, the global orders for the Tumi laparoscopic surgery Siasun Robot & Automation reached 39 units, with over 30 units being commercialized, and nearly 60 units of cumulative commercialized orders worldwide. A Southwest Research report pointed out that the company's "four-fifths" Siasun Robot & Automation layout has been completed, and 2025-2026 will be an important turning point for reversing losses. In addition, the relaxation of domestic configuration certificate policies has led to market expansion. The planned number of laparoscopic surgery Siasun Robot & Automation in the June 2023 edition of the new medical equipment configuration certificate has increased by 215%, with the company's order volume doubling for two consecutive years. The overseas market has rapidly broken through, with 20+ overseas orders approved in the first year of commercialization, and the 5G remote surgery solution has helped in academic promotion and installation in hospitals.